About Us

Xeina Drugs Private Limited is a pharmaceutical licensing company based out of Noida, U.P, India.

Xeina Drugs since its inception in 2017 has been focused on bringing differentiated and specialized products across the emerging markets.

Adhering to our vision to “Make unique finished dosage forms accessible to the emerging markets”, today Xeina has  a rich portfolio of super specialized products in stem cell therapy (innovative therapy from Europe for critical limb ischemia, monoclonal antibodies and generic formulations in multiple sclerosis, immunotherapy and Cardio-vasculars to name a few) by representing some of the leading companies from India (Cadila, Dr. Reddy’s, Ipca, Strides, Caplin) and Europe (Polpharma, Adamed, Biofarm, Axxo Germany).

Our Journey so far

Leadership Team

Ms. Rashmi Kwatra
CEO, Xeina Drugs

An astute pharmaceutical leader with over 22 years of rich and varied experience across various therapeutic categories, business models and geographies. Her core competency lies in super specialized products with a keen focus in Latin America. Rashmi has worked in pharmaceutical companies like Dr Reddy’s, Ranbaxy, Dabur, Jubilant in leadership roles and thereby brings a strategic vision to the company.

Mr. Shashank Mohan
COO, Xeina Drugs

Shashank brings a vast experience of 20 years in International Sales and Marketing with specialization in the Russia CIS Market where he has spent more than 15 years in leadership roles. He also brings robustness in the operational efficiency of the company which he has gathered by working in companies like Dr Reddy’s, Torrent, Ipca and Cadila.

As we all know, "Individually we are one drop, but together we are an ocean!" We, as a company always believe in having integrity, passion and high levels of energy.

For more details visit our website www.xeinadrugs.com